A Father's Search to Cure His Son's Rare Disease

Ilan Ganot is not your typical biotech entrepreneur. When his son Eytani was diagnosed with Duchenne muscular dystrophy, he quit his job as a hedge fund manager with JPMorgan in London, relocated his family to Boston, and launched a company focused exclusively on finding treatments for Duchenne. We spoke to Ganot, CEO and founder of Solid Ventures, about his company, the thinking behind his business model, and whether his approach is transferable to other rare diseases.